Image courtesy of Siemens Healthcare
October 6, 2015 — HealthMyne Inc., a clinical imaging informatics company, has agreed to a research and product evaluation agreement with Moffitt Cancer Center. The primary objective of the agreement is the implementation of an imaging analytics software platform, with an initial focus on thoracic oncology.
One important component of the technology agreement is a structured, mineable repository of de-identified tumor descriptors that will allow investigators to evaluate samples for imaging biomarkers. “The tumor characterization and data mining capabilities that the HealthMyne solution provides will help to accelerate our efforts to identify and validate important radiomic signatures,” said Robert J. Gillies, Ph.D., chair of the Department of Cancer Imaging and Metabolism at Moffitt. “We have moved from viewing images as pictures to seeing them as data, and that is a very empowering clinical care step.”
For more information: www.healthmyne.com
June 15, 2026 
